Arnold & Porter Advises Aurobindo Pharma in FTC Clearance for Acquisition of Lannett Company

Arnold & Porter secured FTC clearance for Aurobindo Pharma’s $250 million acquisition of Lannett Company, negotiating a consent agreement that required divesting four overlapping generic products to Quagen Pharmaceuticals.